Skip to main content
PLI Managing Complex Litigation October 21 Program

PLI Managing Complex Litigation October 21 Program

PLI Managing Complex Litigation October 21 Program
Sponsored by: PLI
Tuesday, October 21, 2014 | 9:00 AM – 12:30 PM
Spotlight on JAMS Speakers: Hon. Carl J. West (Ret.) and Cathy Yanni
Topic: Managing Complex Litigation 2014: Class Actions; Mass Torts & MDL

High-stakes aggregate litigation continues to be an evolving area of practice that has experienced a significant shift due to landmark decisions over the last few years.  Join the notable panel, including Hon. Richard A. Kramer and JAMS neutrals Cathy Yanni and Hon. Carl J. West (Ret.), for a half-day program dedicated to best practices in managing class actions, mass torts, and multidistrict litigation (MDL) throughout the life cycle of these cases, from pretrial class certification and consolidation, through trial or settlement.

What you will learn:
  • The latest trends in complex litigation, including case law and statutory updates
  • Trends in judicial approval of class actions and the award of attorneys
  • Unique issues in class actions, including how courts and litigants deal with objectors
  • Progressive approaches to the management of complex cases

Live at PLI California Center
685 Market Street, San Francisco, California 94105
Also available via webcast.
2.5 General MCLE Credit, 0.5 Ethics MCLE Credit

For further details and to register, please visit the PLI event page.

Featured People

Hon. Carl J. West (Ret.)
  • Antitrust
  • Business/Commercial
  • Class Action/Mass Tort
  • Construction Defect
  • Cybersecurity & Privacy
  • Employment
  • Energy/Utility
  • Entertainment and Sports
  • Environmental
  • Health Care
  • Insurance
  • Intellectual Property
  • Real Property
  • Securities
Cathy Yanni
  • Business/Commercial
  • Civil Rights
  • Class Action/MDL/Mass Tort
  • Cybersecurity & Privacy
  • Employment
  • Health Care
  • Insurance
  • Intellectual Property
  • Life Sciences
  • Personal Injury/Torts
  • Pharmaceuticals/Mass Tort
  • Product Liability
Scroll to top